Pictet Asset Management (Switzerland)’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$25.4M Buy
2023
Q1
$20.3M Buy
2022
Q4
$4.36M Buy
2022
Q3
$4.23M Buy
2022
Q2
$3.15M Buy
2022
Q1
$4.1M Sell
2021
Q4
$4.6M Sell
2021
Q3
$6.5M Buy